Royce & Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-72,600
| Closed | -$852K | – | 1186 |
|
|
2020
Q1 | $852K | Hold |
72,600
| – | – | 0.01% | 759 |
|
|
2019
Q4 | $1.71M | Buy |
72,600
+2,600
| +4% | +$61.1K | 0.02% | 728 |
|
|
2019
Q3 | $1.3M | Hold |
70,000
| – | – | 0.01% | 771 |
|
|
2019
Q2 | $1.3M | Hold |
70,000
| – | – | 0.01% | 806 |
|
|
2019
Q1 | $1.71M | Hold |
70,000
| – | – | 0.01% | 778 |
|
|
2018
Q4 | $1.82M | Buy |
70,000
+5,000
| +8% | +$130K | 0.02% | 760 |
|
|
2018
Q3 | $2.06M | Hold |
65,000
| – | – | 0.01% | 818 |
|
|
2018
Q2 | $2.53M | Sell |
65,000
-17,500
| -21% | -$680K | 0.02% | 774 |
|
|
2018
Q1 | $2.28M | Hold |
82,500
| – | – | 0.02% | 811 |
|
|
2017
Q4 | $1.49M | Buy |
82,500
+15,000
| +22% | +$271K | 0.01% | 900 |
|
|
2017
Q3 | $1.09M | Buy |
67,500
+10,000
| +17% | +$161K | 0.01% | 938 |
|
|
2017
Q2 | $796K | Buy |
+57,500
| New | +$796K | 0.01% | 1006 |
|
|
2015
Q2 | – | Sell |
-59,147
| Closed | -$861K | – | 1226 |
|
|
2015
Q1 | $861K | Sell |
59,147
-111,433
| -65% | -$1.62M | ﹤0.01% | 1042 |
|
|
2014
Q4 | $1.72M | Buy |
+170,580
| New | +$1.72M | 0.01% | 997 |
|